In this study, we observed a significant association between TNF-α and MCP-4 and MDD disease severity that potentiated the cytokine hypothesis in MDD disease development and might pave the way for targeting TNF-α and MCP-4-mediated inflammatory pathways for the development of novel therapies against MDD. Here, CCL13 is linked to major depressive disorder.